Related Experiment Video
Updated: Mar 3, 2026

Real Time and Repeated Measurement of Skeletal Muscle Growth in Individual Live Zebrafish Subjected to Altered Electrical Activity
Published on: June 16, 2022
Activin A more prominently regulates muscle mass in primates than does GDF8
Esther Latres1, Jason Mastaitis1, Wen Fury1
1Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591, USA.
Abstract:
Growth and differentiation factor 8 (GDF8) is a TGF-β superfamily member, and negative regulator of skeletal muscle mass. GDF8 inhibition results in prominent muscle growth in mice, but less impressive hypertrophy in primates, including man. Broad TGF-β inhibition suggests another family member negatively regulates muscle mass, and its blockade enhances muscle growth seen with GDF8-specific inhibition. Here we show that activin A is the long-sought second negative muscle regulator. Activin A specific inhibition, on top of GDF8 inhibition, leads to pronounced muscle hypertrophy and force production in mice and monkeys. Inhibition of these two ligands mimics the hypertrophy seen with broad TGF-β blockers, while avoiding the adverse effects due to inhibition of multiple family members. Altogether, we identify activin A as a second negative regulator of muscle mass, and suggest that inhibition of both ligands provides a preferred therapeutic approach, which maximizes the benefit:risk ratio for muscle diseases in man.
Insights
Growth differentiation factor 8 (GDF8) and activin A are key negative regulators of muscle mass. Inhibiting both GDF8 and activin A promotes significant muscle growth and strength in mice and monkeys, offering a targeted therapy for muscle diseases.
Area of Science:
- Muscle biology
- Skeletal muscle physiology
- TGF-β superfamily signaling
Background:
- Growth differentiation factor 8 (GDF8) negatively regulates skeletal muscle mass.
- GDF8 inhibition causes muscle growth in mice but limited hypertrophy in primates.
- Broad TGF-β inhibition suggests another negative regulator of muscle mass exists.
Purpose of the Study:
- To identify the second negative regulator of muscle mass.
- To investigate the combined effect of inhibiting GDF8 and the identified regulator on muscle growth.
Main Methods:
- Investigated the role of activin A as a negative regulator of muscle mass.
- Administered specific inhibitors for GDF8 and activin A in mice and monkeys.
- Assessed muscle hypertrophy and force production.
Main Results:
- Identified activin A as the second negative regulator of muscle mass.
- Combined inhibition of GDF8 and activin A resulted in pronounced muscle hypertrophy and increased force production in mice and monkeys.
- This dual inhibition strategy mimicked broad TGF-β blockade effects without its adverse effects.
Conclusions:
- Activin A is a crucial negative regulator of skeletal muscle mass.
- Simultaneous inhibition of GDF8 and activin A represents a promising therapeutic strategy for muscle diseases.
- This approach offers an improved benefit:risk ratio for treating muscle wasting conditions in humans.
More Related Videos
09:19A Guide to Examining Intramuscular Fat Formation and its Cellular Origin in Skeletal Muscle
Published on: May 26, 2022
09:49Identification, Isolation, and Characterization of Fibro-Adipogenic Progenitors FAPs and Myogenic Progenitors MPs in Skeletal Muscle in the Rat
Published on: June 9, 2021
Related Concept Videos
Introduction to Actin
Master Transcription Regulators
TGF - β Signaling Pathway
GTPases and their Regulation
GTPases and their Regulation
Large G-proteins,...
GPCRs Regulate Adenylyl Cylase Activity